Unknown

Dataset Information

0

Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia.


ABSTRACT: Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron therapy on platelet counts in patients with IBD-associated anemia.Platelet counts were analyzed before and after iron therapy from four prospective clinical trials. Further, changes in hemoglobin, transferrin saturation, ferritin, C-reactive protein, and leukocyte counts, before and after iron therapy were compared. In a subgroup the effect of erythropoietin treatment was tested. The results were confirmed in a large independent cohort (FERGIcor).A total of 308 patient records were available for the initial analysis. A dose-depended drop in platelet counts (mean 425 G/L to 320 G/L; p<0.001) was found regardless of the type of iron preparation (iron sulphate, iron sucrose, or ferric carboxymaltose). Concomitant erythropoietin therapy as well as parameters of inflammation (leukocyte counts, C-reactive protein) had no effect on the change in platelet counts. This effect of iron therapy on platelets was confirmed in the FERGIcor study cohort (n=448, mean platelet counts before iron therapy: 383 G/L, after: 310 G/L, p<0.001).Iron therapy normalizes elevated platelet counts in patients with IBD-associated anemia. Thus, iron deficiency is an important pathogenetic mechanism of secondary thrombocytosis in IBD.

SUBMITTER: Kulnigg-Dabsch S 

PROVIDER: S-EPMC3323537 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia.

Kulnigg-Dabsch Stefanie S   Evstatiev Rayko R   Dejaco Clemens C   Gasche Christoph C  

PloS one 20120410 4


<h4>Background and aims</h4>Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron therapy on platelet counts in patients with IBD-associated anemia.<h4>Methods</h4>Platelet counts were analyzed before and after iron therapy from four prospective clinical trials. Further, changes  ...[more]

Similar Datasets

| S-EPMC3678593 | biostudies-literature
| S-EPMC7408734 | biostudies-literature
| S-EPMC6878771 | biostudies-literature
| PRJNA943357 | ENA
| S-EPMC3974521 | biostudies-literature
| S-EPMC5937204 | biostudies-literature
2012-09-12 | E-MTAB-184 | biostudies-arrayexpress
2004-04-20 | GSE1152 | GEO
| S-EPMC3846470 | biostudies-literature